| Literature DB >> 27249110 |
Henricus J T A M Huijbregts1,2, Riaz J K Khan1,2,3,4, Emma Sorensen1, Daniel P Fick1,2,3, Samantha Haebich1.
Abstract
Background and purpose - Patient-specific instrumentation (PSI) for total knee arthroplasty (TKA) has been introduced to improve alignment and reduce outliers, increase efficiency, and reduce operation time. In order to improve our understanding of the outcomes of patient-specific instrumentation, we conducted a meta-analysis. Patients and methods - We identified randomized and quasi-randomized controlled trials (RCTs) comparing patient-specific and conventional instrumentation in TKA. Weighted mean differences and risk ratios were determined for radiographic accuracy, operation time, hospital stay, blood loss, number of surgical trays required, and patient-reported outcome measures. Results - 21 RCTs involving 1,587 TKAs were included. Patient-specific instrumentation resulted in slightly more accurate hip-knee-ankle axis (0.3°), coronal femoral alignment (0.3°, femoral flexion (0.9°), tibial slope (0.7°), and femoral component rotation (0.5°). The risk ratio of a coronal plane outlier (> 3° deviation of chosen target) for the tibial component was statistically significantly increased in the PSI group (RR =1.64). No significance was found for other radiographic measures. Operation time, blood loss, and transfusion rate were similar. Hospital stay was significantly shortened, by approximately 8 h, and the number of surgical trays used decreased by 4 in the PSI group. Knee Society scores and Oxford knee scores were similar. Interpretation - Patient-specific instrumentation does not result in clinically meaningful improvement in alignment, fewer outliers, or better early patient-reported outcome measures. Efficiency is improved by reducing the number of trays used, but PSI does not reduce operation time.Entities:
Mesh:
Year: 2016 PMID: 27249110 PMCID: PMC4967282 DOI: 10.1080/17453674.2016.1193799
Source DB: PubMed Journal: Acta Orthop ISSN: 1745-3674 Impact factor: 3.717
Figure 1.Flow diagram of the study.
Baseline characteristics of the studies included
| Author | Country | Patient-specific system | M/F | Conventional Age | BMI | M/F | PSI Age | BMI | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Abane | France | Visionaire | 26/44 | 70 (54–83) | 27 (20–40) | 19/51 | 68 (47–84) | 29 (20–40) |
| 2 | Abdel | France | PSI | 8/12 | 71 (55–83) | 30 (24–41) | 8/12 | 71 (61–81) | 28 (20–36) |
| 3 | Boonen | Netherlands | Signature | 40/50 | 65 ± 8.8 | 30 | 34/56 | 69 ± 8.0 | 30 |
| 4 | Chareancholvanich | Thailand | PSI | 6/34 | 70 (53–85) | 28 (22–40) | 4/36 | 70 (55–84) | 28 (20–44) |
| 5 | Chen | Singapore | PSI | 5/25 | 65 ± 8 | 29 ± 5.8 | 9/20 | 65 ± 8 | 29 ± 6.5 |
| 6 | Chotanaphuti | Thailand | Trumatch | 40 | 69 ± 5.5 | 25 ± 2.1 | 40 | 70 ± 5.5 | 25 ± 2.4 |
| 7 | Ferrara | Italy | PSI | 7/8 | 74 ± 7.2 | 28 ± 3.8 | 6/9 | 75 ± 6.7 | 28 ± 3.6 |
| 8 | Hamilton | USA | Trumatch | 7/19 | 67 (51–88) | 31 (22–38) | 14/12 | 68 (52–86) | 31 (22–40) |
| 9 | Huijbregts | Australia | Visionaire | 32/32 | 69 ± 1.2 | * | 29/40 | 67 ± 1.1 | * |
| 10 | Kotela | Poland | Signature | 13/33 | 68 ± 9.9 | 30 ± 5.6 | 16/33 | 66 ± 8.4 | 30 ± 4.6 |
| 11 | Molicnik | Slovenia | Signature | 5/14 | 66 ± 6.7 | 33 ± 5.5 | 2/17 | 67 ± 7.1 | 32 ± 5.3 |
| 12 | Ng | USA | PSI | 13/14 | 79 ± 8.1 | 31 ± 6.8 | 17/34 | 66 ± 7.5 | 34 ± 6.3 |
| 13 | Noble | USA | Visionaire | 6/8 | 68 (56–80) | 31 (21–40) | 8/7 | 65 (57–76) | 30 (22–35) |
| 14 | Parratte | France | PSI | 20 | * | * | 20 | * | * |
| 15 | Pietsch | Austria | PSI | 19/21 | 69 ± 9.4 | 31 ± 4.9 | 13/27 | 71 ± 6.6 | 29 ± 3.5 |
| 16 | Roh | Korea | Signature | 5/43 | 70 ± 5.1 | 27 ± 2.7 | 3/39 | 70 ± 7.2 | 27 ± 4.2 |
| 17 | Silva | Portugal | Signature | 22 | 74 (71; 80) | * | 23 | 73 (67; 78) | * |
| 18 | Victor | Belgium | Sign/TruM/Vis/PSI | 21/43 | 66 (36–92) | * | 21/43 | 67 (52–87) | * |
| 19 | Vundelinckx | Belgium | Visionaire | 11/20 | 68 ± 8.5 | 31 ± 5.3 | 15/16 | 65 ± 8.2 | 28 ± 3.8 |
| 20 | Woolson | USA | Trumatch | 26/0 | 65 | * | 22/0 | 67.2 | * |
| 21 | Yan | China | PSI | 6/24 | 69 ± 8.4 | * | 13/17 | 68 ± 8.0 | * |
| Total | 782 | 805 |
Means are shown with standard deviation or with range (in parentheses). Where an asterisk is shown, no data were provided. Abdel et al. and Parratte et al. analyzed the same patients. Data by Huijbregts are mean with standard error. Data by Silva are median and interquartile range.
Visionaire: Smith and Nephew, Memphis, TN. PSI: Zimmer, Warsaw, IN. Signature: Biomet, Warsaw, IN. TruMatch: DePuy, Warsaw, IN.
Figure 2.Forest plot for hip-knee-ankle axis outliers per patient-specific system.
Figure 3.Forest plot for coronal tibial outliers
Figure 4.Forest plot for deviation from intended femoral rotation.
Figure 7.Risk-of-bias summary; “–” indicates high risk of bias, “?” indicates unclear risk, and “+” indicates low risk of bias.
Figure 8.Funnel plots. A. Funnel plot of publication bias for deviation of intended hip-knee-ankle axis. B. Funnel plot of publication bias for hip-knee-ankle axis outliers.